Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from 23andMe

This company is launching a genetic matching feature for future parents—and the CEO says ‘it has nothing to do with eugenics’

Nucleus Genomics claims to give couples a picture of their combined risk for passing down hundreds of conditions to their future children.

Fortune

Who Is Sergey Brin? The Billionaire Directing Google's AGI Race And The 60-Hour Workweek Push

Sergey Brin, Google's co-founder, is driving a 60-hour workweek to win the AGI race, a journey rooted in his escape from Russia and rise to billionaire status.

International Business Times UK

23andMe CEO Anne Wojcicki trying to buy DNA testing app she sold for $6bn for just $75m

The CEO has joined forces with venture capital firm New Mountain Capital in the bid to take the company private

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

23andMe was once worth $6 billion. Now CEO Anne Wojcicki wants to buy it back for $42 million

Experts say the CEO’s second attempt to buy back the troubled DNA startup comes with a slew of corporate governance red flags.

Fortune

The fall of 23andMe: How DNA testing lost its way

From $6bn to $50m in four years – how did it all unravel for the DNA pioneer?

Evening Standard

How do DNA tests tell if two people are related?

How can DNA from a cheek swab determine if someone is closely related to you?

LiveScience

Think twice before using a DNA test –they're a privacy nightmare

DNA kits offer fascinating insights into your genetic background, but they might be a privacy nightmare.

Tom’s Guide

Read news from The Economist, FT, and more,
with one subscription

23andMe’s struggles are a sign that direct-to-consumer DNA testing needs stronger oversight

23andMe, a major company providing direct-to-consumer genetic testing, has been struggling financially since late 2023. In September 2024, the company’s stock hit a rock-bottom of US$0.30, down 96 per cent from its peak share price of US$17.65 in 2021.

The Conversation

Why I regret using 23andMe: I gave up my DNA just to find out I’m British

I gave away my genetic information to a now imploding company for results that inspired nothing but ambivalence

The Guardian - US

A Wyoming woman grew up thinking she was an only child. She actually has 50 half-siblings

Lippincott has been on a mission to meet as many of her new-found family members as she can

The Independent UK

23andMe is laying off 40% of its workforce right before the holiday season

The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile data breach, several rounds of previous layoffs and piling losses that plunged the company’s stock over recent years

The Independent UK

After its entire board resigned overnight, 23andMe will cut over 200 employees and its cancer research in an urgent bid to nurse the company back to health

The DNA-testing firm said in a Tuesday SEC filing, “there is substantial doubt about the company’s ability to continue.”

Fortune

23andMe cuts 40% of its workforce and discontinues therapeutics division

23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs

The Independent UK

Genetic testing firm 23andMe cuts 40% of its workforce amid financial struggles

Company says it will cut about 200 employees as value plummets in aftermath of huge data breach

The Guardian - US

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times

23andMe Slashes Workforce By 40%, Ends Therapeutic Programs

Genetic testing company 23andMe will be restructuring the company to save on costs.

RideApart

CFMoto Debuts First-Ever V4 Engine, Doesn't Tell Us a Single Thing About It

V4 engines are all the rage right now. Whether it's Ducati, KTM, or Yamaha, everyone's got to have one to compete at the tippy top of the superbike spear. So it's no wonder that newcomer, but heavy-weight player, CFMoto would be not only developing a V4 platform but saving its…

Fortune

23andMe appoints three former CFOs as new directors—after the previous board all resigned

The genetic testing company, once worth $6 billion, has lost most of its value.

The Guardian - AU

Hold the front page: Sydney Morning Herald forgoes Lidia Thorpe protest in favour of sneezing alpaca

Herald and the Age opt not to use photograph of Thorpe wearing possum-skin cloak and shaking her fist at King Charles on page one. Plus: The Australian fails to read fine print

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

Behind the scenes at 23andMe, questions about a star CEO

Some past employees weren’t exactly surprised when the entire board at 23andMe tester quit last month

The Conversation

A giant biotechnology company might be about to go bust. What will happen to the millions of people’s DNA it holds?

Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies in the world. Millions of people have used its simple genetic testing service, which involves ordering a saliva test, spitting into a tube, and sending it back to the company for a…

Fortune

23andMe’s entire board resigned on the same day. Founder Anne Wojcicki still thinks the startup is savable

The blue-chip board and the startup star had been on a collision course for months. Here’s what really happened.

Fortune

Does 23andMe have your DNA? Take these steps to delete your data

23andMe has recently come under fire. What does that mean for its 15 million customers?

Fortune

Exclusive: Avid Ventures raises $87 million second fund

Avid Ventures has raised $87 million for its second fund, Fortune can exclusively report.

The Guardian - US

All 23andMe board members but CEO resign over no adequate buyout offers

The board has rejected both of Anne Wojcicki’s buyout proposals to save the struggling genetics company

Fortune

Every single member of the board just resigned from DNA tester 23andMe

CEO Anne Wojcicki said the mass exodus left her “surprised and disappointed.”

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.